Transcatheter aortic valve replacement during the COVID-19 pandemic-A Dutch single-center analysis.

Maxim J P RooijakkersWilson W L LiLaurens W L M WollersheimGuillaume S C GeuzebroekHelmut GehlmannLeen A F M van GarsseMarleen H van WelyMichel W A VerkroostWim J MorshuisHeiman WertheimNiels van Royen

Published in: Journal of cardiac surgery (2020)

A continued TAVR program during the COVID-19 pandemic is feasible despite limited hospital resources. However, COVID-19 related mortality after TAVR is of concern.

Keyphrases

transcatheter aortic valve replacement
aortic stenosis
aortic valve
coronavirus disease
sars cov
healthcare
quality improvement
emergency department
heart failure
acute care
atrial fibrillation
respiratory syndrome coronavirus
coronary artery disease
electronic health record